Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica

Area of Science:

• Immunology
• Microbiology
• Parasitology

Background:

• Entamoeba histolytica causes amebiasis, ranging from asymptomatic infections to severe colitis and liver abscesses.
• Complement-mediated lysis is a crucial host defense mechanism against pathogens.
• Previous studies indicated a correlation between E. histolytica virulence and resistance to serum killing.

Purpose of the Study:

• To investigate the complement activation and lysis resistance mechanisms of pathogenic versus nonpathogenic Entamoeba histolytica strains.
• To determine the roles of the classical and alternative complement pathways in the lysis of E. histolytica.

Main Methods:

• Assessing complement depletion using CH50, C3, C7, and C5-9 hemolytic activities.
• Evaluating lysis by normal human serum (NHS) with and without chelators (EGTA, EDTA).
• Testing lysis using complement-deficient sera (C4-deficient guinea pig serum, C2-deficient human serum).

Main Results:

• Both pathogenic and nonpathogenic E. histolytica strains rapidly depleted complement components.
• Alternative pathway activation was essential for the lysis of nonpathogenic strains.
• Pathogenic strains were resistant to lysis mediated by both classical and alternative complement pathways, despite activating complement.
• Classical pathway activation occurred for all strains but was not essential for lysis.

Conclusions:

• Pathogenic Entamoeba histolytica activates the complement system but effectively evades complement-mediated lysis.
• This evasion of a critical host defense mechanism likely contributes to the virulence of pathogenic E. histolytica strains.
• Understanding these evasion strategies may reveal new therapeutic targets for amebiasis.